psychotic disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The participant has a diagnosis of a psychotic disorder. 2. Psychotic symptoms are in remission for at least three months for first episode psychosis and at least six months for multiple episode psychosis. 3. Age 16-65 years. 4. The participant understands the study and is able to provide written informed consent. 5. The participant is not participating in a medication study. 6. The participant is currently using antipsychotic medication and participant and his/her treating clinician agree to discontinuation/dose reduction. Patients with depot medication can also participate. 7. Sufficient command of the Dutch language. 8. Sufficient vision to read the questions in the PsyMate app and sufficient hearing to hear the PsyMate signals.
Exclusion criteria
Exclusion criteria: Exclusion criteria are kept as few as possible. Only when the safety of the participant is at risk, exclusion will follow. Patients will be excluded from the trial if patients are not in remission (at least 3 months for first episode patients and at least 6 months for multiple episodes) .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Momentary mental states and behaviour in terms of psychotic experiences, subjective well-being (positive affect, negative affect, physical well-being), social interactions, sleep, cognition, dopamine super-sensitivity and negative symptoms in the context of daily life. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms, mental health and functioning, recovery, physical complaints/side effects, quality of life | — |
Countries
Netherlands
Contacts
GGzE